The latest announcement is out from Genscript Biotech ( (HK:1548) ).
Genscript Biotech Corporation announced a supplemental release regarding the financial results of its listed associate, Legend Biotech Corporation, for the fourth quarter and the year ended December 31, 2024. The announcement includes a Chinese translation of Legend Biotech’s press release, originally published in English, detailing financial performance and recent business highlights. Stakeholders are advised to consider investment risks carefully.
More about Genscript Biotech
Genscript Biotech Corporation is a company incorporated in the Cayman Islands, operating in the biotechnology industry. It is listed on the Hong Kong Stock Exchange and has a focus on developing and providing innovative biotechnological products and services.
YTD Price Performance: 13.39%
Average Trading Volume: 3,834
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $3.52B
Learn more about 1548 stock on TipRanks’ Stock Analysis page.